Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

de novo myelodysplastic syndromes

Known as: de novo Myelodysplastic Syndrome, untreated myelodysplastic syndromes, myelodysplastic syndromes, de novo 
A primary myelodysplastic syndrome not associated with prior radiation or chemotherapy treatment.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The Revised International Prognostic Scoring System (IPSS-R) was developed for untreated myelodysplastic syndrome (MDS) patients… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2013
Highly Cited
2013
PURPOSE Myelodysplastic syndromes (MDS) are clonal hematopoietic disorders that are more common in patients aged ≥ 60 years and… Expand
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Therapy-related myelodysplastic syndromes and acute myelogenous leukemia comprise a poor-risk subset of myelodysplastic syndromes… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2011
Highly Cited
2011
This cooperative study assessed prognostic factors for overall survival (OS) and risk of transformation to acute myeloid leukemia… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
2009
2009
Deletions spanning chromosome 5q31.2 are among the most common recurring cytogenetic abnormalities detectable in myelodysplastic… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) are positive regulators of… Expand
Is this relevant?
Highly Cited
1996
Highly Cited
1996
YELODYSPLASTIC syndromes (MDS) are a group M of clonal hematologic disorders characterized by progressive cytopenia. Some… Expand
Is this relevant?
Highly Cited
1993
Highly Cited
1993
Although the prognostic value of cytogenetic analysis has previously been demonstrated in myelodysplastic syndromes (MDS… Expand
Is this relevant?
Highly Cited
1991
Highly Cited
1991
We treated 47 adult patients with de novo myelodysplastic syndrome (MDS) by an anthracycline-AraC regimen. Median age was 54, and… Expand
Is this relevant?
Highly Cited
1986
Highly Cited
1986
In a study of 56 consecutive adult patients with de novo myelodysplastic syndromes (MDS), all cases were successfully analyzed… Expand
  • table 1
  • table 1
  • table 2
  • table 2
  • figure 1
Is this relevant?